Medical - Devices
Compare Stocks
2 / 10Stock Comparison
AMIX vs MDT
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
AMIX vs MDT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Medical - Devices |
| Market Cap | $675K | $99.94B |
| Revenue (TTM) | $0.00 | $35.48B |
| Net Income (TTM) | $-17M | $4.61B |
| Gross Margin | — | 61.9% |
| Operating Margin | — | 17.9% |
| Forward P/E | — | 14.1x |
| Total Debt | $0.00 | $28.52B |
| Cash & Equiv. | $9M | $2.22B |
AMIX vs MDT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 24 | May 26 | Return |
|---|---|---|---|
| Autonomix Medical, … (AMIX) | 100 | 0.4 | -99.6% |
| Medtronic plc (MDT) | 100 | 89.1 | -10.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMIX vs MDT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMIX is the clearest fit if your priority is growth exposure.
- EPS growth 69.4%
MDT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 36 yrs, beta 0.47, yield 3.6%
- 26.5% 10Y total return vs AMIX's -99.6%
- Lower volatility, beta 0.47, Low D/E 59.1%, current ratio 1.85x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.6% revenue growth vs AMIX's -27.8% | |
| Quality / Margins | 13.0% margin vs AMIX's 1.8% | |
| Stability / Safety | Beta 0.47 vs AMIX's 1.00 | |
| Dividends | 3.6% yield; 36-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -2.8% vs AMIX's -78.9% | |
| Efficiency (ROA) | 175.8% ROA vs AMIX's -168.8% |
AMIX vs MDT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AMIX vs MDT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AMIX leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
MDT and AMIX operate at a comparable scale, with $35.5B and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $0 | $35.5B |
| EBITDAEarnings before interest/tax | -$17M | $9.4B |
| Net IncomeAfter-tax profit | -$17M | $4.6B |
| Free Cash FlowCash after capex | -$12M | $5.4B |
| Gross MarginGross profit ÷ Revenue | — | +61.9% |
| Operating MarginEBIT ÷ Revenue | — | +17.9% |
| Net MarginNet income ÷ Revenue | — | +13.0% |
| FCF MarginFCF ÷ Revenue | — | +15.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +8.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +75.3% | -11.9% |
Valuation Metrics
AMIX leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $675,318 | $99.9B |
| Enterprise ValueMkt cap + debt − cash | -$8M | $126.2B |
| Trailing P/EPrice ÷ TTM EPS | -0.06x | 21.60x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.13x |
| PEG RatioP/E ÷ EPS growth rate | — | 36.00x |
| EV / EBITDAEnterprise value multiple | — | 14.32x |
| Price / SalesMarket cap ÷ Revenue | — | 2.98x |
| Price / BookPrice ÷ Book value/share | 0.08x | 2.08x |
| Price / FCFMarket cap ÷ FCF | — | 19.28x |
Profitability & Efficiency
MDT leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
MDT delivers a 9.4% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-2 for AMIX. On the Piotroski fundamental quality scale (0–9), MDT scores 6/9 vs AMIX's 2/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -2.0% | +9.4% |
| ROA (TTM)Return on assets | -168.8% | +175.8% |
| ROICReturn on invested capital | — | +6.0% |
| ROCEReturn on capital employed | -138.5% | +7.5% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 |
| Debt / EquityFinancial leverage | — | 0.59x |
| Net DebtTotal debt minus cash | -$9M | $26.3B |
| Cash & Equiv.Liquid assets | $9M | $2.2B |
| Total DebtShort + long-term debt | $0 | $28.5B |
| Interest CoverageEBIT ÷ Interest expense | -375.57x | 9.08x |
Total Returns (Dividends Reinvested)
MDT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MDT five years ago would be worth $7,230 today (with dividends reinvested), compared to $38 for AMIX. Over the past 12 months, MDT leads with a -2.8% total return vs AMIX's -78.9%. The 3-year compound annual growth rate (CAGR) favors MDT at -1.4% vs AMIX's -84.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -28.8% | -18.1% |
| 1-Year ReturnPast 12 months | -78.9% | -2.8% |
| 3-Year ReturnCumulative with dividends | -99.6% | -4.2% |
| 5-Year ReturnCumulative with dividends | -99.6% | -27.7% |
| 10-Year ReturnCumulative with dividends | -99.6% | +26.5% |
| CAGR (3Y)Annualised 3-year return | -84.4% | -1.4% |
Risk & Volatility
MDT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MDT is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than AMIX's 1.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MDT currently trades 73.3% from its 52-week high vs AMIX's 14.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.00x | 0.47x |
| 52-Week HighHighest price in past year | $2.64 | $106.33 |
| 52-Week LowLowest price in past year | $0.32 | $77.16 |
| % of 52W HighCurrent price vs 52-week peak | +14.5% | +73.3% |
| RSI (14)Momentum oscillator 0–100 | 50.6 | 27.3 |
| Avg Volume (50D)Average daily shares traded | 132K | 7.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
MDT is the only dividend payer here at 3.57% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $109.50 |
| # AnalystsCovering analysts | — | 49 |
| Dividend YieldAnnual dividend ÷ price | — | +3.6% |
| Dividend StreakConsecutive years of raises | — | 36 |
| Dividend / ShareAnnual DPS | — | $2.78 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.2% |
MDT leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). AMIX leads in 2 (Income & Cash Flow, Valuation Metrics).
AMIX vs MDT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is AMIX or MDT a better buy right now?
Medtronic plc (MDT) offers the better valuation at 21.
6x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate Medtronic plc (MDT) a "Buy" — based on 49 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AMIX or MDT?
Over the past 5 years, Medtronic plc (MDT) delivered a total return of -27.
7%, compared to -99. 6% for Autonomix Medical, Inc. Common Stock (AMIX). Over 10 years, the gap is even starker: MDT returned +26. 5% versus AMIX's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AMIX or MDT?
By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.
47β versus Autonomix Medical, Inc. Common Stock's 1. 00β — meaning AMIX is approximately 114% more volatile than MDT relative to the S&P 500.
04Which is growing faster — AMIX or MDT?
On earnings-per-share growth, the picture is similar: Autonomix Medical, Inc.
Common Stock grew EPS 69. 4% year-over-year, compared to 30. 8% for Medtronic plc. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AMIX or MDT?
Medtronic plc (MDT) is the more profitable company, earning 13.
9% net margin versus 0. 0% for Autonomix Medical, Inc. Common Stock — meaning it keeps 13. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MDT leads at 17. 8% versus 0. 0% for AMIX. At the gross margin level — before operating expenses — MDT leads at 65. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — AMIX or MDT?
In this comparison, MDT (3.
6% yield) pays a dividend. AMIX does not pay a meaningful dividend and should not be held primarily for income.
07Is AMIX or MDT better for a retirement portfolio?
For long-horizon retirement investors, Medtronic plc (MDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
47), 3. 6% yield). Both have compounded well over 10 years (MDT: +26. 5%, AMIX: -99. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between AMIX and MDT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AMIX is a small-cap quality compounder stock; MDT is a mid-cap income-oriented stock. MDT pays a dividend while AMIX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.